Wang et al., 2013 - Google Patents
Determination of CK2 specificity and substrates by proteome-derived peptide librariesWang et al., 2013
- Document ID
- 2225798891697811459
- Author
- Wang C
- Ye M
- Bian Y
- Liu F
- Cheng K
- Dong M
- Dong J
- Zou H
- Publication year
- Publication venue
- Journal of proteome research
External Links
Snippet
Understanding the specificity of kinases enables prediction of their substrates and uncovering kinase functions in signaling pathways. Traditionally synthesized peptide libraries are used to determine the kinase specificity. In this study, a proteomics-based …
- 239000000758 substrate 0 title abstract description 133
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Malik et al. | Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages | |
Wang et al. | Determination of CK2 specificity and substrates by proteome-derived peptide libraries | |
Wisniewski et al. | Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis | |
Dau et al. | Proteomics using protease alternatives to trypsin benefits from sequential digestion with trypsin | |
Shiromizu et al. | Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project | |
Chapman et al. | Mapping PARP-1 auto-ADP-ribosylation sites by liquid chromatography–tandem mass spectrometry | |
Tsai et al. | Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics | |
Cantin et al. | Quantitative phosphoproteomic analysis of the tumor necrosis factor pathway | |
Bantscheff et al. | Chemoproteomic approaches to drug target identification and drug profiling | |
Crowe et al. | Ubiquitin chain enrichment middle-down mass spectrometry enables characterization of branched ubiquitin chains in cellulo | |
Chang et al. | Analysis of protein phosphorylation by hypothesis-driven multiple-stage mass spectrometry | |
Petkowski et al. | Substrate specificity of mammalian N-terminal α-amino methyltransferase NRMT | |
Lemeer et al. | Online automated in vivo zebrafish phosphoproteomics: from large-scale analysis down to a single embryo | |
Kanshin et al. | Sample preparation and analytical strategies for large-scale phosphoproteomics experiments | |
Turk | Understanding and exploiting substrate recognition by protein kinases | |
Wang et al. | Antibody-free approach for the global analysis of protein methylation | |
De Graaf et al. | Signal transduction reaction monitoring deciphers site-specific PI3K-mTOR/MAPK pathway dynamics in oncogene-induced senescence | |
Kaushik et al. | The expression pattern of the phosphoproteome is significantly changed during the growth phases of recombinant CHO cell culture | |
Zhang et al. | Comparison of three quantitative phosphoproteomic strategies to study receptor tyrosine kinase signaling | |
Dong et al. | Depletion of acidic phosphopeptides by SAX to improve the coverage for the detection of basophilic kinase substrates | |
Zhou et al. | Online Nanoflow RP− RP-MS Reveals Dynamics of Multicomponent Ku Complex in Response to DNA Damage | |
Kaleja et al. | Combination of SCX fractionation and charge-reversal derivatization facilitates the identification of nontryptic peptides in C-terminomics | |
Lu et al. | Combinatorial histone H3 modifications are dynamically altered in distinct cell cycle phases | |
Xu et al. | Mass spectrometry analysis of phosphopeptides after peptide carboxy group derivatization | |
Moran et al. | Emerging applications for phospho-proteomics in cancer molecular therapeutics |